2021
DOI: 10.3389/ijph.2021.619011
|View full text |Cite
|
Sign up to set email alerts
|

Burden of Disease Methods: A Guide to Calculate COVID-19 Disability-Adjusted Life Years

Abstract: This publication is based upon work from COST Action CA18218 (European Burden of disease Network-www.

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
77
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7
2

Relationship

3
6

Authors

Journals

citations
Cited by 59 publications
(77 citation statements)
references
References 20 publications
0
77
0
Order By: Relevance
“…For the computation of DALY, three different approaches to calculate the CDW as mentioned by Hilderink et al 15 were used. The DALY estimates and productivity losses were computed as done by Wyper et al 32 and Rumisha et al 33…”
Section: Validationmentioning
confidence: 99%
“…For the computation of DALY, three different approaches to calculate the CDW as mentioned by Hilderink et al 15 were used. The DALY estimates and productivity losses were computed as done by Wyper et al 32 and Rumisha et al 33…”
Section: Validationmentioning
confidence: 99%
“…The modelling approach to calculating DALYs was based on the COVID-19 consensus model and methods outlined by the European Burden of Disease Network and the European Centre for Disease Prevention and Control (ECDC). 20 Death counts were aggregated by five-year age-group and sex to calculate YLL. For the purposes of YLL calculations, the under-5 years age-group was split into under 1 year and 1 to 4 years, and the upper open-ended age-group was set at 95 years and above.…”
Section: Analysesmentioning
confidence: 99%
“…Our disease model for health loss due to COVID-19 morbidity is based on a published consensus method outlined by the European Burden of Disease Network and the ECDC. 20 This method can be adapted for both prevalence-or pathogen-based YLD calculations. In our SBOD study, we largely use prevalence-based YLD calculations across our cause list, which means that any future indirect effects from COVID-19 following infection in those with "long COVID", such as circulatory or respiratory conditions, would be attributed to their relevant non-communicable disease group through prevalence estimates.…”
Section: Strengths and Weaknessesmentioning
confidence: 99%
“…Due to the enormous rate of spread of the pandemic, longterm, multi-center, case control studies are needed (27). In addition, the authors of this report postulate the need to look for a standardized panel of diagnostic tests, which, given the ubiquitous pandemic, would allow the identification of a group of people at particular risk of developing first-time psychosis spectrum disorders.…”
Section: Discussionmentioning
confidence: 99%